within Pharmacolibrary.Drugs.ATC.N;

model N05CD06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 1.6666666666666667e-05,
    adminDuration  = 600,
    adminMass      = 2 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.085,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008333333333333333,
    Tlag           = 12.0
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N05CD06</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Lormetazepam is a short-to-intermediate acting benzodiazepine hypnotic used primarily for the short-term management of insomnia. It exerts its effect by enhancing the activity of gamma-aminobutyric acid (GABA) at the GABAA receptor. Lormetazepam is approved in several European countries, but is not currently approved by the FDA in the United States.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported in healthy adult volunteers, both male and female, aged 20 to 40 years.</p><h4>References</h4><ol><li><p>Hümpel, M, et al., &amp; Kurowski, M (1979). The pharmacokinetics and biotransformation of the new benzodiazepine lormetazepam in humans. I. Absorption, distribution, elimination and metabolism of lormetazepam-5-14C. <i>European journal of drug metabolism and pharmacokinetics</i> 4(4) 237–243. DOI:<a href=&quot;https://doi.org/10.1007/BF03189433&quot;>10.1007/BF03189433</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/43806/&quot;>https://pubmed.ncbi.nlm.nih.gov/43806</a></p></li><li><p>Luscombe, DK (1984). Lormetazepam--plasma concentrations in volunteers following sublingual and oral dosing. <i>Psychopharmacology. Supplementum</i> 1 99–104. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6147846/&quot;>https://pubmed.ncbi.nlm.nih.gov/6147846</a></p></li><li><p>Doenicke, A, et al., &amp; Täuber, U (1991). [The pharmacokinetics of lormetazepam following cimetidine]. <i>Der Anaesthesist</i> 40(12) 675–679. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1685875/&quot;>https://pubmed.ncbi.nlm.nih.gov/1685875</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N05CD06;
